Vortioxetine: Clinical Pharmacokinetics and Drug Interactions

Vortioxetine is a novel antidepressant with multimodal activity currently approved for the treatment of major depressive disorder. Vortioxetine is orally administered once daily at 5- to 20-mg doses. The pharmacokinetics of vortioxetine are linear and dose proportional, with a mean terminal half-lif...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Grace, Højer, Astrid-Maria, Areberg, Johan, Nomikos, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973995/
https://www.ncbi.nlm.nih.gov/pubmed/29189941
http://dx.doi.org/10.1007/s40262-017-0612-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973995/
https://www.ncbi.nlm.nih.gov/pubmed/29189941
http://dx.doi.org/10.1007/s40262-017-0612-7

Ejemplares similares